Substrate‐Bound β‐Amyloid Peptides Inhibit Cell Adhesion and Neurite Outgrowth in Primary Neuronal Cultures

Accumulation of theβ‐amyloid protein (Aβ) in the brain is an important step in the pathogenesis of Alzheimer's disease. However, the mechanism of Aβ toxicity remains unclear. Aβ can bind to the extracellular matrix, a structure that regulates adhesive events such as neurite outgrowth and synaptogenesis. The binding of Aβ to the extracellular matrix suggests that Aβ may disrupt cell‐substrate interactions. Therefore, the effect of substrate‐bound Aβ on the growth of isolated chick sympathetic and mouse cortical neurons was examined. Aβ1‐40 and Aβ1‐42 had dose‐dependent effects on cell morphology. When tissue culture plates were coated with 0.1‐10 ng/well Aβ, neurite outgrowth increased. Higher amounts of Aβ peptides (≥μg/well) inhibited outgrowth. The inhibitory effect was related to aggregation of the peptide, as preincubation of Aβ1‐40 for 24 h at 37 °C (a process known to increase amyloid fibril formation) was necessary for inhibition of neurite outgrowth. Aβ29‐42, but not Aβ1‐28, also inhibited neurite outgrowth at high concentrations, demonstrating that the inhibitory domain is located within the hydrophobic C‐terminal region. Aβ1‐40, Aβ1‐42, and Aβ29‐42 also inhibited cell‐substrate adhesion, indicating that the effect on neurite outgrowth may have been due to inhibition of cell adhesion. The results suggest that accumulation of Aβ may disrupt cell‐adhesion mechanisms in vivo.

[1]  C. Barrow,et al.  The Aβ 3-Pyroglutamyl and 11-Pyroglutamyl Peptides Found in Senile Plaque Have Greater β-Sheet Forming and Aggregation Propensities in Vitro than Full-Length Aβ† , 1999 .

[2]  David H. Small,et al.  Alzheimer's Disease and the Amyloid β Protein , 1999 .

[3]  F. Engert,et al.  Dendritic spine changes associated with hippocampal long-term synaptic plasticity , 1999, Nature.

[4]  M. Hasselmo,et al.  Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Reiner,et al.  Regulation of Amyloid Precursor Protein Cleavage , 1999, Journal of neurochemistry.

[6]  George B. Benedek,et al.  Temperature dependence of amyloid β-protein fibrillization , 1998 .

[7]  C. Masters,et al.  Survival of Cultured Neurons from Amyloid Precursor Protein Knock-Out Mice against Alzheimer’s Amyloid-β Toxicity and Oxidative Stress , 1998, The Journal of Neuroscience.

[8]  Bruce A. Yankner,et al.  Aging renders the brain vulnerable to amyloid β-protein neurotoxicity , 1998, Nature Medicine.

[9]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Tolar,et al.  Sympathetic neurite outgrowth is greater on plaque-poor vs. plaque-rich regions of Alzheimer's disease cryostat sections , 1998, Brain Research.

[11]  J. Hardy,et al.  Increased Aβ42(43) from cell lines expressing presenilin 1 mutations , 1998, Annals of neurology.

[12]  T. Wight,et al.  Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability , 1997 .

[13]  C. Behl Amyloid β-protein toxicity and oxidative stress in Alzheimer’s disease , 1997, Cell and Tissue Research.

[14]  D. Peterson,et al.  Mechanism of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction , 1997, Journal of neurochemistry.

[15]  N. Inestrosa,et al.  Laminin inhibits amyloid-β-peptide fibrillation , 1996, Neuroscience Letters.

[16]  D. Small,et al.  Role of Proteoglycans in Neural Development, Regeneration, and the Aging Brain , 1996, Journal of neurochemistry.

[17]  B. Yankner Mechanisms of Neuronal Degeneration in Alzheimer's Disease , 1996, Neuron.

[18]  D. Small,et al.  Expression of the amyloid protein precursor of Alzheimer's disease in the developing rat olfactory system. , 1995, Brain research. Developmental brain research.

[19]  V. Nurcombe,et al.  Cholinergic regulation of neurite outgrowth from isolated chick sympathetic neurons in culture , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  B. Yankner,et al.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  L. Thal,et al.  Lack of long-term effects after β-amyloid protein injections in rat brain , 1994, Neurobiology of Aging.

[22]  S. Younkin,et al.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.

[23]  D. Snow,et al.  Interactions of developing neurons with the extracellular matrix , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  D. McLachlan,et al.  Alzheimer Aβ Amyloid Forms an Inhibitory Neuronal Substrate , 1994 .

[25]  B. Hyman,et al.  Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.

[26]  N. Inestrosa,et al.  Extracellular matrix components and amyloid in neuritic plaques of Alzheimer's disease. , 1993, General pharmacology.

[27]  L. Reichardt,et al.  Extracellular Matrix 2: Role of extracellular matrix molecules and their receptors in the nervous system , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[29]  D. Selkoe,et al.  Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Delacourte,et al.  Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide , 1993, Brain Research.

[31]  P. Fraser,et al.  Effects of Sulfate Ions on Alzheimer β/A4 Peptide Assemblies: Implications for Amyloid Fibril‐Proteoglycan Interactions , 1992, Journal of neurochemistry.

[32]  Brian J Cummings,et al.  beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. , 1992, Neuroreport.

[33]  C. Masters,et al.  The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth , 1992, Neuron.

[34]  E. Masliah,et al.  Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease , 1992, Brain Research.

[35]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  Carl W. Cotman,et al.  In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.

[37]  M. Beal,et al.  An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Ulrich,et al.  Alzheimer's Disease: A Description of the Structural Lesions , 1991, Brain pathology.

[39]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[40]  James L. McClelland,et al.  Amnesia and distributed memory , 1986 .

[41]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P C Letourneau,et al.  Cell-to-substratum adhesion and guidance of axonal elongation. , 1975, Developmental biology.

[43]  V. Nurcombe,et al.  Avian sympathetic ganglia , 1999 .

[44]  C. Franceschi,et al.  In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[45]  D. Small,et al.  Alzheimer's disease and the amyloid beta protein: What is the role of amyloid? , 1999, Journal of neurochemistry.

[46]  B. Greenberg,et al.  An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[47]  E. Engvall,et al.  Extracellular matrix components , 1994 .

[48]  D. Selkoe,et al.  Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity. , 1993, The American journal of pathology.

[49]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.

[50]  Effects of injected Alzheimer f3-amyloid cores in rat brain , 2022 .